Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting
Go back to Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting| (NASDAQ: CRBU) | Delayed: 1.64 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.64 | 52 Week High | $ | |||
| Open | $1.63 | 52 Week Low | $ | |||
| Day High | $1.69 | P/E | N/A | |||
| Day Low | $1.62 | EPS | $ | |||
| Volume | 604,161 | |||||
